These results of this study corroborated with the previous findings by showing that highly PHF5A expression is associated with either poorer clinical stage of tumor or shorter survival time of patients in NSCLC [8, 9], breast cancer [11] or colorectal cancer [12, 13]. Here, PHF5A is linked to non-small cell lung carcinoma.